A recent study titled “Prevalence and Risk of Behavioral Symptoms among Patients with Insomnia and Alzheimer’s Disease: A Retrospective Database Analysis” has unveiled a significant link between diagnosed insomnia and a higher prevalence of behavioral symptoms in patients with Alzheimer’s Disease (AD).
Led by Dr. Farid Chekani, a PhD who is affiliated with the Center for Observational and Real-World Evidence (CORE) at Merck & Co., the research team conducted a retrospective cohort analysis involving over 7,800 patients. The findings revealed that individuals with insomnia were significantly more likely to develop behavioral symptoms compared to those without the sleep disorder.
For more insights, check out the interview with Dr. Chekani on Physician’s Weekly.
Supporters
